Navigation Links
Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
Date:8/9/2012

PHILADELPHIA, Aug. 9, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced that Platinum-Montaur Life Sciences, LLC (Montaur) will provide Echo a credit facility of up to $20 million. The company believes that this transaction will provide Echo with the capital resources needed to implement Echo's plans to commercialize Symphony.

(Logo: http://photos.prnewswire.com/prnh/20120801/NE50071LOGO )

The commitment letter provides that Echo will be able to borrow up to $5 million initially, at 10% interest per annum.  Upon attaining certain key regulatory and clinical study objectives, the credit facility will increase in $3 million increments, with a maximum increase of $15 million. On closing, Echo will issue Montaur 4 million warrants with a term of five years and an exercise price of $2 per share.  Additionally, Echo will issue 1 million five year warrants per $1 million borrowed, with an exercise price ranging from $2 to $4 per share, depending on the market price of Echo's common stock at the time of the applicable draw. The loan matures five years from the date of closing.

"We are pleased that this new facility allows us to balance our capital structure while attempting to minimize dilution to our shareholders.  We believe the increased liquidity and financial flexibility provided by this financial commitment will enhance our ability to aggressively move Symphony toward regulatory clearance in both Europe and the United States," said Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics.  "Montaur has proven to be a trusted source
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015  With the heroin ... reaching deadlier heights, Jacksonville -based Lakeview ... Hemphill is helping to explain why fentanyl is ... approximately 40 to 50 times more potent than pharmaceutical ... users as heroin, the risk of death skyrockets. ...
(Date:8/28/2015)... August 28, 2015 According to ... Tumor (Breast, Lung, Prostate) Type (Protein & Genetic Biomarkers) ... Discovery, Prognostic) & Geography - Global Forecast to 2020", ... to reach around 17,689.0 Million USD by 2020 at ... 2015 to 2020. Browse 191 Tables ...
(Date:8/28/2015)... Research and Markets ... the "12th Annual Report and Survey of ... their offering. The 2015 12th Annual ... Production is the most recent study of biotherapeutic ... future capacity and production. The report contains the ...
Breaking Medicine Technology:Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 512th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2
... NEW YORK, Jan. 28, 2011 Get content ... http://www.thenewsmarket.com/Releases/StoryDetailPage.aspx?GUID=edb04e54-24b1-41bc-b1f7-aac03a4e0b31&lr=ls British Prime Minister David ... double its current contribution to polio eradication. Mr. ... Global Polio Eradication Initiative as he announced the ...
... 28, 2011 Drug safety remains front and center ... agency strives to improve the public,s perception of the ... its reputation among consumers and recognizes that its diligence ... role in that effort. One issue that ...
Cached Medicine Technology:Navigating the Gray Areas of Post-Marketing Surveillance 2
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a ... for two years, the longest of any cellulite reduction system currently on the market. ... effective solution for their cellulite, according to Dr. Robert Weiss, director of the premier ...
(Date:8/28/2015)... ... 28, 2015 , ... On May 30th, 2015, Best Drug Rehabilitation, a results-based ... With A Mission” benefit concert in Mendon, IL. Held in the Show Barn at ... support music education programs in the underfunded local school districts of Mendon at neighboring ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL ... with zero fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 ... 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... documenting and diagramming network and data center assets and audio-video devices, recently released ... Cisco Nexus 5000 Series, HP ProLiant Gen9, EMC VNX Series , Super Micro ...
(Date:8/28/2015)... ... ... Medical Solutions, one of the nation’s largest travel nurse staffing companies, has ... Healthcare and will be honored at an awards dinner in Chicago on Wednesday, ... to Work in Healthcare program recognizes outstanding employers in the healthcare industry nationwide. Modern ...
Breaking Medicine News(10 mins):Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3
... but 24.6% of these are not based on any scientific ... at Baza Hospital (Granada), published in the journal BMC Public ... primary and secondary school text books in order to identify ... classified them into three categories messages with a high, ...
... common practices of health care providers who see adolescent ... clinician and researcher at Women & Infants Hospital of ... an adolescent medicine specialist at Hasbro Children,s Hospital, asserted ... for teenagers who are sexually active. This includes ...
... HealthDay Reporter , THURSDAY, March 24 (HealthDay News) ... into the world of viable treatments, scientists have successfully fashioned ... fall victim to the onset of age-related macular degeneration, or ... which have been the subject of much debate in recent ...
... , This press release is available in French ... of Optics of the University of Granada , belonging to ... a programme for testing alterations in night vision, and the tool ... instrument consists on a software named Software Halo v1.0, and a ...
... Helena Johansson, Research fellow at the Centre for Bone ... Dr. Maria-Belen Zanchetta, Research fellow at the Instituto de ... the winners of the 2011 ESCEO-AMGEN Fellowship. ... Aspects of Osteoporosis and Osteoarthritis (ESCEO) with support from ...
... PA, March 23, 2011 Although acupuncture is commonly ... safety remain. Investigators from the Universities of Exeter & ... Medicine (Daejeon, South Korea) critically evaluated systematic reviews of ... explore this question. Reporting in the April 2011 issue ...
Cached Medicine News:Health News:Around 25 percent of health messages in Spanish text books are not based on scientific evidence 2Health News:Researchers: Sexually active teens need confidential health care 2Health News:Researchers: Sexually active teens need confidential health care 3Health News:Progress Seen in Creating Eye Cells From Stem Cells 2Health News:Progress Seen in Creating Eye Cells From Stem Cells 3Health News:Researchers develop a halometer that tests alterations in night vision 2Health News:Researchers develop a halometer that tests alterations in night vision 3Health News:Acupuncture for pain no better than placebo and not without harm 2
Rees bayonet forceps, standard, 5-1/2", TC....
... Channel Implants, designed to accept ... surgeon with an excellent reconstructive ... and floor blowout defects. Each ... placement of one or more ...
... is designed to augment areas ... midface, including the inferior orbital ... in the hollow under the ... implant aids in restoring the ...
The new Inferior Medial Orbital Rim Implant (IMORI) provides surgeons with an excellent alternative for patients with a deficient or recessed "tear trough" area often characterized as a look of fatig...
Medicine Products: